Lexis Nexis’s The Drugs and Cosmetics Act, 1940 (Bare Act) – 2021 Edition
Original price was: ₹695.00.₹530.00Current price is: ₹530.00.
Lexis Nexis’s The Drugs and Cosmetics Act, 1940 along with Rules, 1945 as amended by (Ninth Amendment) Rules, 2017 along with allied Act and Rules (Bare Act) – 2021 Edition. The Drugs and Cosmetics Act, 1940 (23 of 1940) with • The Drugs and Cosmetics Rules, 1945 as amended by (Twelfth Amendment) Rules, 2019 • The Drugs (Control) Act, 1950 Repealed by the Repealing and Amending Act, 2016 (23 of 2016).
Details
- Binding : Softcover
- Publisher : Lexis Nexis
- Author : Universal
- Edition : 2021
- Language : English
- ISBN-10 : D8
- ISBN-13 : D8
Related products
-
Read more
FEMA & FDI Ready Reckoner provides complete and accurate information about all provisions of the Foreign Exchange Management Act, 1999 (FEMA). It also includes guidance on all practical issues faced by companies and FEMA professionals. Key features of this book are as follows: Topic-wise commentary on FEMA Analysis of all provisions of FEMA with relevant …
-
Read more
Taxmann’s Companies Act 2013 covers the Amended, Updated & Annotated text of the Companies Act, 2013 [as amended by the Companies (Amendment) Act 2020]. What sets it apart is the presentation/coverage of the Companies Act with corresponding Rules, Circulars & Notifications. In other words, the Annotation under each Section shows: Relevant Rules framed under the relevant Section Reference …
-
Read more
Taxmann’s Companies Act with Rules is the most authentic and comprehensive book, in a Pocket Paperback format, on Companies Act, 2013. It covers the Amended, Updated & Annotated text of the Companies Act, 2013 (‘Act’) and the Rules prescribed thereunder along with Circulars & Notifications [as amended by the Companies (Amendment) Act 2020]. This book …
-
Add to cart
This book aims to explain the readers how to read, understand, analyse and interlink the voluminous information available in the financial statement with the help of charts, case analysis, etc. In other words, this book provides in-depth analysis, stepwise approach with the use of case analysis, to understand & decode the financial statements.
Reviews
There are no reviews yet.